CCL20 is a potential therapeutic target associated with immune infiltration in breast cancer
Objectives CCL20 is a chemotactic factor that is involved in immune cell recruitment and cancer progression. However, the role of CCL20 in the prognosis of breast cancer remains unclear. This study analyzed correlations between CCL20 expression and immune infiltration, clinicopathological parameters...
Main Authors: | Hongyan Zhai, Na Zhang, Dan Mo, Tingting Qin |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2023-08-01
|
Series: | Journal of International Medical Research |
Online Access: | https://doi.org/10.1177/03000605231171762 |
Similar Items
-
Modulation of the CCR6-CCL20 Axis: A Potential Therapeutic Target in Inflammation and Cancer
by: Ranmali Ranasinghe, et al.
Published: (2018-11-01) -
Identification of GZMA as a Potential Therapeutic Target Involved in Immune Infiltration in Breast Cancer by Integrated Bioinformatical Analysis
by: Huo Q, et al.
Published: (2023-03-01) -
Cathepsin a upregulation in glioma: A potential therapeutic target associated with immune infiltration
by: Zhang Ming, et al.
Published: (2022-01-01) -
Regulation of CCL2 by EZH2 affects tumor-associated macrophages polarization and infiltration in breast cancer
by: Ya-fang Wang, et al.
Published: (2022-08-01) -
CCL22 and CCL26 are potential biomarkers for predicting distant metastasis in thyroid carcinoma
by: Junyu Tong, et al.
Published: (2022-12-01)